• HOME
  • TEVAR-Twin
  • COMPANY
  • CAB
  • PARTNERS
  • NEWS
  • CONTACT

A digital twin technology to revolutionize stent-graft selection for precise, patient-specific surgeries

Achieve perfect procedural outcomes every time with confidence

TEVAR-Twin Solution

LEARN MORE
TEVAR-Twin offers AI/ML-enabled precision medicine, user-friendly software needing only pre-surgical patient CT images. It relies on clinically-validated high-fidelity numerical models to guide surgeons in selecting the “best-fit” stent-graft.
PATIENTS

51

digital twins with research collaboration with Politecnico di Milano
Clinical centres

34

in 11 countries across Europe and North America
Patents

2

and >10 scientific publications on peer-reviewed journals

About AllStent

LEARN MORE
The AllStent is a MedTech company founded by a team with >50-years experience in numerical modelling through global collaborations with leading vascular surgeons and stent-graft manufacturers. Additionally, we have deep expertise in MedTech start-up financing and commercialization, and are pursuing US and EU regulatory clearances.

Testimonials

Santi Trimarchi, MD Policlinico di Milano Hospital (Italy)
The presence kinking prediction and post-operative validation made the results of the simulation very credible.
Javiér Rio Gomez, MD Hospital General Universitario Gergorio Maranon (Spain)
Before simulations, I didn’t expect big changes in stent configuration changing landing zone. It's interesting to realize how landing zone affects on stent expansion
Theodoros Kratimenos, MD Evangelismos General Hospital of Athens (Greece)
Preoperative simulation can be a game changer as predicts possible device misalignment and the best strategy for the patient-specific case!

our partners

Latest News

April 10th, 2025
In the press: "Corriere della Sera"
Surgical stents, plant-based sushi, and instant diagnostics: the startups of Berkeley SkyDeck Europe in search of investors
Read more >>
April 2nd, 2025
AllStent Joins Berkeley SkyDeck Europe, Secures €145k Investment

"We are excited to join SkyDeck and leverage its world-class ecosystem to accelerate our growth and impact in TEVAR surgery", Paul Chipperton, CEO
Read more >>
October 28th, 2024
AllStent Accepted into the ECHO 2025 Experiential Training Program to compete for C$250,000 prize
ECHO Entrepreneurship, Canada, is training the next generation of innovators in all aspects of advancing cardiovascular care. The program aims to bridge the translational gap for cardiovascular innovations.
Read more >>
SEE ALL OUR NEWS
Copyright © All rights reserved.
Address
123 Front Street West Suite 1503, Toronto ON M5J 2M2
Contact
ceo@allstent.com +1 647 291 8545

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.